Perspective
Accepted on 31 Oct 2025
Advances in the study of reversing tumor drug resistance by targeting cancer-associated fibroblasts with nanomaterials
in Cancer Immunity and Immunotherapy
Perspective
Accepted on 31 Oct 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 31 Oct 2025
in Emergency Health Services
Original Research
Accepted on 31 Oct 2025
in Public Mental Health
Systematic Review
Accepted on 31 Oct 2025
in Movement Science
Original Research
Accepted on 31 Oct 2025
in Microbial Symbioses
Original Research
Accepted on 31 Oct 2025
in Children and Health
Editorial
Accepted on 31 Oct 2025
in Psychopharmacology
Original Research
Accepted on 31 Oct 2025
in Public Health Education and Promotion
Original Research
Accepted on 31 Oct 2025
in Rheumatology
Original Research
Accepted on 31 Oct 2025
in Organizational Psychology
Review
Accepted on 31 Oct 2025
in Inflammation
Hypothesis and Theory
Accepted on 31 Oct 2025
in Oral Health Promotion
Review
Accepted on 31 Oct 2025
in Tissue Engineering and Regenerative Medicine
Original Research
Accepted on 31 Oct 2025
in Dermatology
Review
Accepted on 31 Oct 2025
in Systems Microbiology
Correction
Accepted on 31 Oct 2025
in Neurodegeneration